Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma

Keon Mahmoudi, Daniel H. Kim, Elham Tavakkol, Shingo Kihira, Adam Bauer, Nadejda Tsankova, Fahad Khan, Adilia Hormigo, Vivek Yedavalli, Kambiz Nael

Research output: Contribution to journalArticlepeer-review


Background: Clinical, histopathological, and imaging variables have been associated with prognosis in patients with glioblastoma (GBM). We aimed to develop a multiparametric radiogenomic model incorporating MRI texture features, demographic data, and histopathological tumor biomarkers to predict prognosis in patients with GBM. Methods: In this retrospective study, patients were included if they had confirmed diagnosis of GBM with histopathological biomarkers and pre-operative MRI. Tumor segmentation was performed, and texture features were extracted to develop a predictive radiomic model of survival (<18 months vs. ≥18 months) using multivariate analysis and Least Absolute Shrinkage and Selection Operator (LASSO) regularization to reduce the risk of overfitting. This radiomic model in combination with clinical and histopathological data was inserted into a backward stepwise logistic regression model to assess survival. The diagnostic performance of this model was reported for the training and external validation sets. Results: A total of 116 patients were included for model development and 40 patients for external testing validation. The diagnostic performance (AUC/sensitivity/specificity) of the radiomic model generated from seven texture features in determination of ≥18 months survival was 0.71/69.0/70.3. Three variables remained as independent predictors of survival, including radiomics (p = 0.004), age (p = 0.039), and MGMT status (p = 0.025). This model yielded diagnostic performance (AUC/sensitivity/specificity) of 0.77/81.0/66.0 (training) and 0.89/100/78.6 (testing) in determination of survival ≥ 18 months. Conclusions: Results show that our radiogenomic model generated from radiomic features at baseline MRI, age, and MGMT status can predict survival ≥ 18 months in patients with GBM.

Original languageEnglish
Article number589
Issue number3
StatePublished - Feb 2024


  • MGMT
  • MRI
  • glioma
  • multiparametric
  • radiogenomics
  • texture analysis
  • tumor segmentation


Dive into the research topics of 'Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma'. Together they form a unique fingerprint.

Cite this